Anomic suicides on rise during recently emerging crises: Revisiting Durkheim's model
CNS Spectr. 2023 Jul 10:1-5. doi: 10.1017/S1092852923002341. Online ahead of print.NO ABSTRACTPMID:37424313 | DOI:10.1017/S1092852923002341 (Source: CNS Spectrums)
Source: CNS Spectrums - July 10, 2023 Category: Neurology Authors: Sujita Kumar Kar Shivangini Singh Source Type: research
Neuropsychiatric phenotypes in functional movement disorder
CNS Spectr. 2023 Jul 10:1-35. doi: 10.1017/S1092852923002353. Online ahead of print.NO ABSTRACTPMID:37424291 | DOI:10.1017/S1092852923002353 (Source: CNS Spectrums)
Source: CNS Spectrums - July 10, 2023 Category: Neurology Authors: Gabriela S Gilmour Laura K Langer Anthony E Lang Lindsey MacGillivray Sarah C Lidstone Source Type: research
Anomic suicides on rise during recently emerging crises: Revisiting Durkheim's model
CNS Spectr. 2023 Jul 10:1-5. doi: 10.1017/S1092852923002341. Online ahead of print.NO ABSTRACTPMID:37424313 | DOI:10.1017/S1092852923002341 (Source: CNS Spectrums)
Source: CNS Spectrums - July 10, 2023 Category: Neurology Authors: Sujita Kumar Kar Shivangini Singh Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report
CONCLUSION: Higher pre-treatment levels of IFN-Γ and CCL-2 were associated with non-response to escitalopram. Increasing levels of these pro-inflammatory markers may be associated with non-response to adjunctive aripiprazole. These findings require validation in independent clinical populations.PMID:37218291 | DOI:10.1017/S109285292300233X (Source: CNS Spectrums)
Source: CNS Spectrums - May 23, 2023 Category: Neurology Authors: M Ishrat Husain Jane A Foster Brittany L Mason Sheng Chen Haoyu Zhao Wei Wang Susan Rotzinger Sakina Rizvi Keith Ho Raymond Lam Glenda MacQueen Roumen Milev Benicio N Frey Daniel M üller Gustavo Turecki Manish Jha Madhukar Trivedi Sidney H Kennedy Source Type: research
